NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG
Phase 1 Study of NIR Fluorescence Guided Thoracic Surgery Using ICG
1 other identifier
interventional
36
1 country
1
Brief Summary
This study aims to first apply near-infrared fluorescence imaging technology in thoracic surgery with indocyanine green in China. To evaluate the feasibility usage of the investigators' fluorescence imaging systems and the safety applications in intraoperative sentinel lymph node mapping of lung and esophageal cancer, lung nodule imaging, lung segment resection boundary determination, esophagus - tubular anastomosis, thoracic duct imaging and chylothorax repairing thoracic surgery. Aim to achieve precise boundaries definition during thoracic surgery and realize accurate, minimally invasive thoracic surgery with fluorescence imaging technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1 lung-cancer
Started Aug 2015
Shorter than P25 for phase_1 lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 16, 2015
CompletedFirst Posted
Study publicly available on registry
November 20, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedJune 8, 2018
June 1, 2018
1.2 years
November 16, 2015
June 6, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection rates of lung nodes with fluorescence imaging
Participants will be followed for the duration of hospital stay, an expected average of 1 year
1 year
Study Arms (1)
Indocyanine green
EXPERIMENTALThis group of patients under general anesthesia to accept conventional thoracoscopy or thoracotomy. Before systematic lymphadenectomy, four-point of ICG with 10mg was injected in normal lung tissue around the tumor. After 3-5 minutes, fluorescence and white-light images were collected and recorded in real-time. With the guidance of intraoperative images, all fluorescent lymph nodes were removed and sent to routine pathological confirmation.
Interventions
This group of patients accepted intravenous injection from 0.5mg / kg to 5mg / kg ICG within 4 to 24 hours before surgery. All patients under general anesthesia to accept conventional thoracoscopy or thoracotomy. After entering the chest using fluorescence thoracoscopy system to collect the fluorescence and white-light images and record the video. After following the routine preoperative planning surgery, the researchers will carefully assess the possibility of the benign and malignant nodules and to communicate with the families of patients. If the patient's family expressed their willingness to dissect the nodules, the researchers will remove this extra pulmonary nodules. Resected specimens will send to routine pathological confirmation compared with the fluorescence results.
Eligibility Criteria
You may qualify if:
- Pulmonary nodules undergoing thoracoscopy or thoracotomy
- Esophageal cancer patients who underwent radical surgery
- Preoperative liver function is normal
- No indocyanine green and iodine allergies, and indocyanine green skin test negative
- Volunteered to participate in this study and signed informed consent in this study
You may not qualify if:
- Preoperative liver dysfunction
- Indocyanine green or iodine allergies, or indocyanine green skin test positive
- Not combined with other well-controlled comorbidities
- Clinicians considered unsuitable for enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chinese Academy of Scienceslead
- Peking Universitycollaborator
Study Sites (1)
Key Laboratory of Molecular Imaging, Chinese Academy of Sciences
Beijing, Beijing Municipality, 100190, China
Related Publications (4)
Chi C, Du Y, Ye J, Kou D, Qiu J, Wang J, Tian J, Chen X. Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology. Theranostics. 2014 Aug 15;4(11):1072-84. doi: 10.7150/thno.9899. eCollection 2014.
PMID: 25250092BACKGROUNDMao Y, Chi C, Yang F, Zhou J, He K, Li H, Chen X, Ye J, Wang J, Tian J. The identification of sub-centimetre nodules by near-infrared fluorescence thoracoscopic systems in pulmonary resection surgeries. Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1190-1196. doi: 10.1093/ejcts/ezx207.
PMID: 28950327RESULTYang F, Zhou J, Li H, Yang F, Xiao R, Chi C, Tian J, Wang J. Near-infrared fluorescence-guided thoracoscopic surgical intervention for postoperative chylothorax. Interact Cardiovasc Thorac Surg. 2018 Feb 1;26(2):171-175. doi: 10.1093/icvts/ivx304.
PMID: 29049798DERIVEDLi H, Zhou J, Chi C, Mao Y, Yang F, Tian J, Wang J. Clinical application of near-infrared thoracoscope with indocyanine green in video-assisted thoracoscopic bullectomy. J Thorac Dis. 2016 Jul;8(7):1841-5. doi: 10.21037/jtd.2016.06.02.
PMID: 27499979DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jian Zhou, Doctor
Peking University People's Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Key Laboratory of Molecular Imaging, Chinese Academy of Sciences
Study Record Dates
First Submitted
November 16, 2015
First Posted
November 20, 2015
Study Start
August 1, 2015
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
June 8, 2018
Record last verified: 2018-06